Rapport Therapeutics, Inc.
RAPPCIK 0002012593 · last filing Jul 1, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
0 bought / 18,220 sold
net −18,220 sh · −$743.2K
- buys
- 0
- sells
- 6
- insiders active
- 2
Filing tape
Filed Wed, Jul 1, 2026
- −10,000 sh · $415.8K
Gault Cheryl — Chief Operating Officer
- Sold1,900Common Stock@ $40.09→ 158,014 held
- Sold3,792Common Stock@ $41.39→ 154,222 held
- Sold3,308Common Stock@ $42.17→ 150,914 held
- Sold1,000Common Stock@ $43.15→ 149,914 held
- −8,220 sh · $327.4K
Ceesay Abraham — Chief Executive Officer · Director
- Sold7,344Common Stock@ $39.77→ 548,903 held
- Sold876Common Stock@ $40.34→ 548,027 held
Insiders on this tape
- Gault CherylChief Operating Officer
- Ceesay AbrahamChief Executive Officer · Director
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.